Senna and Tobi drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Senna (senna) and Tobi (tobramycin). Common drug interactions include affective disorder among females and cough among males.

The phase IV clinical study analyzes what interactions people have when they take Senna and Tobi. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Senna?

Senna has active ingredients of senna. It is often used in constipation. eHealthMe is studying from 37,302 Senna users. Check the latest studies of Senna.

What is Tobi?

Tobi has active ingredients of tobramycin. eHealthMe is studying from 10,011 Tobi users. Check the latest studies of Tobi.



On Aug, 02, 2026

36 people who take Senna and Tobi together, and have interactions are studied.

Senna and Tobi drug interactions.

What are the common drug interactions of Senna and Tobi, by gender? *:

female:

  1. Affective disorder (mental disorder)
  2. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  3. Alveolar osteitis (complication of wound healing following extraction of a tooth)
  4. Anaemia (lack of blood)
  5. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  6. Arthralgia (joint pain)
  7. Atelectasis (partial or complete collapse of the lung)
  8. Back pain
  9. Blood magnesium decreased
  10. Blood sodium decreased

male:

  1. Cough
  2. Dyspnoea (difficult or laboured respiration)
  3. Asthma
  4. Blood pressure decreased
  5. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
  6. Chest discomfort
  7. Chills (felling of cold)
  8. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  9. Clubbing (deformity of the fingers and fingernails)
  10. Cystic fibrosis related diabetes

What are the common drug interactions of Senna and Tobi, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Suicidal ideation
  2. Abdominal pain upper
  3. Anxiety
  4. Depression
  5. Hypnopompic hallucination
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  8. Panic attack
  9. Sleep paralysis (waking up and unable to move or speak)

20-29:

  1. Abdominal pain
  2. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  3. Blood glucose increased
  4. Bronchial wall thickening
  5. Epistaxis (bleed from the nose)
  6. Pancreatitis acute (sudden inflammation of pancreas)
  7. Pulmonary mass
  8. Hemiparesis (weakness on one side of the body)
  9. Pain
  10. Syringomyelia (cavity forms within the spinal cord)

30-39:

  1. Dyspnoea (difficult or laboured respiration)
  2. Productive cough
  3. Cystic fibrosis (disease of the secretary glands)
  4. Abdominal pain
  5. Asthenia (weakness)
  6. Chest pain
  7. Confusional state
  8. Cough
  9. Decreased appetite
  10. Dizziness

40-49:

  1. Dyspnoea (difficult or laboured respiration)
  2. Social problem

50-59:

  1. Arthropathy
  2. Exostosis (formation of new bone on the surface of a bone)
  3. Pain in extremity
  4. Shoulder operation
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints)

60+:

  1. Depression
  2. Asthenia (weakness)
  3. Alveolar osteitis (complication of wound healing following extraction of a tooth)
  4. Anaemia (lack of blood)
  5. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  6. Anxiety
  7. Arthralgia (joint pain)
  8. Atelectasis (partial or complete collapse of the lung)
  9. Back pain
  10. Blood magnesium decreased

What are the existing conditions these people have? *

  1. Cystic Fibrosis (disease of the secretary glands): 30 people, 83.33%
  2. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 7 people, 19.44%
  3. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 7 people, 19.44%
  4. Sinusitis (inflammation of sinus): 6 people, 16.67%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 16.67%
  6. Stress And Anxiety: 2 people, 5.56%
  7. Seasonal Allergy (allergic condition due to certain season): 2 people, 5.56%
  8. Panic Disorder: 2 people, 5.56%
  9. Pain: 2 people, 5.56%
  10. Insomnia (sleeplessness): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Senna and Tobi?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Senna and Tobi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Senna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tobi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Senna and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tobi and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on senna and tobramycin (the active ingredients of Senna and Tobi, respectively), and Senna and Tobi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: